Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 06 16; 127(24):3092-4.
View in:
PubMed
subject areas
ADAMTS13 Protein
ADAMTS13 Protein
Adrenal Cortex Hormones
Adrenal Cortex Hormones
Adult
Adult
Aged
Aged
Female
Female
Humans
Humans
Immunologic Factors
Immunologic Factors
Male
Male
Middle Aged
Middle Aged
Plasma Exchange
Plasma Exchange
Purpura, Thrombotic Thrombocytopenic
Purpura, Thrombotic Thrombocytopenic
Recurrence
Recurrence
Rituximab
Rituximab
Secondary Prevention
Secondary Prevention
Young Adult
Young Adult
authors with profiles
James N George
Sara Vesely